Acrux: Acrux shares gain after FDA approves its toenail fungus treatment
After a tumultuous journey, biotech Acrux (ASX:ACR) will finally be able to sell its toenail fungus treatment in the USA. ... Read More The post Acrux shares gain after FDA approves its toenail fungus treatment appeared first on Stockhead.
Read full article »
Acrux is an Australia-based pharmaceutical company that develops and commercializes specialty and generic topical medicines for the healthcare industry.
Read more